Cells as Vehicles for Cancer Gene Therapy: The Missing Link Between Targeted Vectors and Systemic Delivery?-Reference-Cited by-同舟云学术

Cells as Vehicles for Cancer Gene Therapy: The Missing Link Between Targeted Vectors and Systemic Delivery?

Published:2002-07-20 Issue:11 Volume:13 Page:1263-1280
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Harrington Kevin¹,Alvarez-Vallina Luis²,Crittenden Marka³,Gough Michael³,Chong Heung³,Diaz Rosa Maria³,Vassaux Georges⁴,Lemoine Nicholas⁴,Vile Richard³

Affiliation:

1. Cancer Research Campaign, Centre for Cell and Molecular Biology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, UK and Molecular Medicine Program, Guggenheim 18, Mayo Foundation, Rochester, MN 55905.

2. Department of Immunology, Hospital Universitario Clinica Puerta de Hierro, 28035 Madrid, Spain.

3. Molecular Medicine Program, Guggenheim 18, Mayo Foundation, Rochester, MN 55905

4. ICRF Molecular Oncology Unit, Imperial College School of Medicine at Hammersmith Hospital, London W12 0HS, UK.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303402760128504

Reference165 articles.

1. Complementary adenoviral vectors for oncolysis

2. Replicative adenoviruses for cancer therapy

3. Blood clearance rates of adenovirus type 5 in mice

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway;Cell Death Discovery;2022-02-08

2. Immune cells as tumor drug delivery vehicles;Journal of Controlled Release;2020-11

3. Mononuclear but Not Polymorphonuclear Phagocyte Depletion Increases Circulation Times and Improves Mammary Tumor-Homing Efficiency of Donor Bone Marrow-Derived Monocytes;Cancers;2019-11-08

4. Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders;Journal of Cellular Physiology;2019-11-06

5. Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers;Molecular Therapy - Oncolytics;2019-03